Haematological Disorders
Conditions
Interventions
Ferrous sulphate and vitamin C supplements.
Ferrous Sulphate
Sponsors
Egeonu Yochi Immaculata
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Absence of signs of fatigue, weakness, normal skin colour and mucous membranes with no jaundice, cyanosis. Absence of clinical signs of disease/ill health (HIV, malaria, sickle cell). Having a weight more than 50 kg. Male and female blood donors within the age bracket of 18 to 59 years. Female having no menstrual cycle. Willingness to give informed consent to the study. Blood donors who are resident in Calabar metropolis irrespective of place of birth, educational, religious and ethnic, background. Blood donors who are present at the designated health facilities. Blood donors aged (18-59) years, who are not already taking iron and vitamin C tablets.
Exclusion criteria
Exclusion criteria: All blood donors aged below 18 and above 59 years, who do not meet the inclusion criteria pregnant and lactating women female blood donors on menstrual cycles having a weight less than 50 kg, mentally vulnerable Donors with conditions associated with gastrointestinal blood loss a personal or family history of hereditary hemochromatosis, cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i.At least 90% improvement in mean levels of haemoglobin, PCV, and meam cell haemoglobin concentration of the study subjects. ii. At least 85% of the study subjects should understand anaemia and its symptoms.Iii. At least 85% of the study subjects should know about the preventive measures of anaemia. | — |
Secondary
| Measure | Time frame |
|---|---|
| i. Subjects must demonstrate at least 80% adherence to supplements with assessment of compliance and self-reported side effects. ii.At least 90% of the subjects will resolve to take up and adhere to anaemia treatment option after blood donation. | — |
Countries
Nigeria
Contacts
Public ContactMagaret Akpan
Senior Lecturer
Outcome results
None listed